| Financial Year |
March 31 2023 |
| Monetary Funds |
1,051,383,767.03 |
| Held-for-trading Financial Assets |
56,285.13 |
| Notes Receivable |
-- |
| Accounts Receivable |
441,453,671.38 |
| Advances to Suppliers |
347,276,797.92 |
| Other Receivables |
49,138,121.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,294,764,620.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,446,752.39 |
| Total Current Assets |
3,322,027,522.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,166,229.57 |
| Long-term Equity Investment |
120,044,607.82 |
| Investment Properties |
457,284,038.18 |
| Fixed Assetes |
1,034,791,932.71 |
| Under-construction Projects |
1,003,344,675.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,064,509.79 |
| R&D expenses |
-- |
| Goodwill |
32,285,220.01 |
| Long-Term Deferred and Prepaid Expenses |
2,166,704.95 |
| Deferred Income Tax Assets |
103,408,118.51 |
| Other Non-Current Assets |
6,400,882.84 |
| Sub-Total of Non-Current Assets |
4,803,032,364.46 |
| Total Assets |
8,125,059,886.80 |
| Short-Term Loans |
1,561,419,377.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,533,521.41 |
| Accounts Payable |
140,233,884.89 |
| Accounts Received In Advance |
4,246,736.40 |
| Employee Compensation Payable |
12,306,237.96 |
| Taxes Payable |
3,084,833.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
92,690,073.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,645,783.50 |
| Other Current Liabilities |
14,106,775.49 |
| Sub-Total of Current Liabilities |
2,269,066,648.37 |
| Long-term Loans |
1,392,306,006.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
46,022,724.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
288,745,276.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,786,797,692.46 |
| Total Liabilities |
4,055,864,340.83 |
| Paid-In Capital(Or Share Stock) |
1,001,914,821.00 |
| Capital Surplus |
2,942,457,603.14 |
| Surplus Reserve |
101,631,156.33 |
| LESS:Treasury Stock |
106,669,664.25 |
| Undistributed Profits |
88,123,958.20 |
| Minority Stockholder's Interest |
35,742,087.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,033,453,458.13 |
| Owner's Equity（Stockholder's Equity） |
4,069,195,545.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,125,059,886.80 |
